Sign Up to Receive Your Personalised Learning Resources
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
ESMO 2023: Putting patients first – cultivating care in bladder cancer
Advancements in Immune Checkpoint Inhibitors for Oesophageal Squamous Cell Carcinoma: Current Status and Future Perspectives
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer
Capivasertib + paclitaxel for metastatic triple-negative breast cancer did not meet threshold for improving overall survival
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
Advances in Targeting KRAS G12C in Gastrointestinal Malignancies: Focus on KRAS G12C Inhibitors
Cell-based Genetic Therapy for the Induction of Foetal Haemoglobin in Sickle Cell Disease and Transfusion-dependent β-thalassaemia
Front-line consolidation therapy in B-ALL: current challenges and novel strategies
Transarterial chemoembolization with lenvatinib and pembrolizumab showed improvement in progression-free survival for hepatocellular carcinoma
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
View
Advancing upper gastrointestinal cancer care: Insights from Dr Ken Kato on Japan’s clinical research and future innovations
View
PERSEUS trial results: Daratumumab + VRd in newly diagnosed multiple myeloma: ASH 2023, Pieter Sonneveld
View
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
View
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results
View
Guideline-based treatment of recurrent/metastatic cervical cancer
View
Precision oncology – predicting future risk in early breast cancer (eBC)
View
Harnessing the power of precision medicine for the treatment of colorectal cancer
View
Findings from the XTEND-Kids Study: Efanesoctocog Alfa for Severe Haemophilia A in Children
View
Trastuzumab deruxtecan shows clinical benefit in patients with HER2-ultralow metastatic breast cancer
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
